Martin H. Bolli

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Marc Iglarz, Christoph A. Binkert, Keith Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 325 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Pyranosyl-RNA: chiroselective self-assembly of base sequences by ligative oligomerization of tetra nucleotide-2′,3′-cyclophosphates (with a commentary concerning the origin of biomolecular homochirality)

Martin H. Bolli, Ronald Micura, Albert Eschenmoser · Chemistry & Biology · 1997 · 287 citations · Full text

Life Sciences, Biology, Molecular Biology +15

2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P₁Receptor Agonists

Martin H. Bolli, Stefan Abele, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2010 · 178 citations · Full text

Medicine, Immunology, Pharmacology +17

The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

Martin H. Bolli, Christoph Boss, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2012 · 148 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Nucleic‐Acid Analogues with Constraint Conformational Flexibility in the Sugar‐Phosphate Backbone (‘Bicyclo‐DNA’). Part 1. Preparation of (3<i>S</i>,5′<i>R</i>)‐2′‐Deoxy‐3′,5′‐ethano‐αβ‐<scp>D</scp>‐ribonucleosides (‘Bicyclonucleosides’)

Markus Tarköy, Martin H. Bolli, W. Bernd Schweizer et al. · Helvetica Chimica Acta · 1993 · 128 citations

Life Sciences, Biochemistry, Molecular Biology +17